Archived News

Study Confirms Value Of Low-Dose Aspirin

Stopping low-dose aspirin treatment increases the risk of non-fatal myocardial infarction for patients with a history of heart disease by nearly two-thirds, according to a BMJ study (online 19 July 2011).

Using the UK Health Improvement Network database, investigators identified 39,513 patients aged 50–84 years who were prescribed low-dose aspirin for the secondary prevention of cardiovascular disease between 2000 and 2007. From this primary-care dataset, 1,222 patients who subsequently experienced a non-fatal myocardial infarction or died from heart disease were identified and compared with 5,000 controls.

To read the full story click here.

Extract taken from PJ Online